Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 18777534)

Published in J Magn Reson Imaging on September 01, 2008

Authors

Hai-Ling Margaret Cheng1

Author Affiliations

1: Research Institute, Department of Diagnostic Imaging, Hospital for Sick Children, Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada. hai-ling.cheng@sickkids.ca

Associated clinical trials:

Non-Invasive Imaging of Atherosclerosis | NCT01418313

Articles citing this

A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer. Phys Med Biol (2011) 1.15

The promise of dynamic contrast-enhanced imaging in radiation therapy. Semin Radiat Oncol (2011) 1.12

Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. J Cereb Blood Flow Metab (2009) 1.08

The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer. Semin Oncol (2011) 1.07

Model-based blind estimation of kinetic parameters in dynamic contrast enhanced (DCE)-MRI. Magn Reson Med (2009) 1.00

The MRI-measured arterial input function resulting from a bolus injection of Gd-DTPA in a rat model of stroke slightly underestimates that of Gd-[14C]DTPA and marginally overestimates the blood-to-brain influx rate constant determined by Patlak plots. Magn Reson Med (2010) 0.98

The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data. Magn Reson Med (2010) 0.97

Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastases. BMC Med Phys (2009) 0.97

Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI. Eur Radiol (2009) 0.94

Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy. J Oncol (2010) 0.93

Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters. Acad Radiol (2010) 0.93

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge. Tomography (2016) 0.89

A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: I. Simulations. Phys Med Biol (2010) 0.88

Correction of arterial input function in dynamic contrast-enhanced MRI of the liver. J Magn Reson Imaging (2012) 0.86

Comparison of dynamic contrast-enhanced MRI and quantitative SPECT in a rat glioma model. Contrast Media Mol Imaging (2012) 0.83

Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging (2015) 0.81

Simultaneous measurement of kidney function by dynamic contrast enhanced MRI and FITC-sinistrin clearance in rats at 3 tesla: initial results. PLoS One (2013) 0.81

DCE-MRI of the liver: reconstruction of the arterial input function using a low dose pre-bolus contrast injection. PLoS One (2014) 0.80

Arterial input function calculation in dynamic contrast-enhanced MRI: an in vivo validation study using co-registered contrast-enhanced ultrasound imaging. Eur Radiol (2012) 0.79

Three-dimensional dynamic contrast enhanced imaging of the carotid artery with direct arterial input function measurement. Magn Reson Med (2013) 0.77

Mitotic Activity in Glioblastoma Correlates with Estimated Extravascular Extracellular Space Derived from Dynamic Contrast-Enhanced MR Imaging. AJNR Am J Neuroradiol (2015) 0.76

Establishment of a lung metastatic breast tumor xenograft model in nude rats. PLoS One (2014) 0.75

Simultaneous measurement of T1 /B1 and pharmacokinetic model parameters using active contrast encoding (ACE)-MRI. NMR Biomed (2017) 0.75